par Strollo, Rocky;Vinci, Chiara ;Napoli, Nicola;Fioriti, Elvira;Maddaloni, Ernesto;Åkerman, Linda;Casas, Rosaura;Pozzilli, Paolo;Ludvigsson, Johnny;Nissim, Ahuva
Référence Diabetes/metabolism research and reviews, 35, 4, page (e3132)
Publication Publié, 2019-01-01
Référence Diabetes/metabolism research and reviews, 35, 4, page (e3132)
Publication Publié, 2019-01-01
Article révisé par les pairs
Résumé : | Antibodies to posttranslationally modified insulin (oxPTM-INS-Ab) are a novel biomarker of type 1 diabetes (T1D). Here, we evaluated whether oxPTM-INS-Ab can improve T1D prediction in children with positive standard islet autoantibodies (AAB). |